Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Mol Cancer Ther. 2016 Mar 4;15(6):1353–1363. doi: 10.1158/1535-7163.MCT-15-0332

Figure 1. Edelfosine and AD inhibits cell proliferation in LNCaP cells.

Figure 1

LNCaP cells (2 × 104) were grown in E-Plates for 24 h in complete or AD medium. Cells were treated with edelfosine (1, 2.5, 5, 10 and 20 μM) with appropriate control groups (A) LNCaP and (B) LNCaP + AD. Cells were monitored and cell proliferation was measured in real time by RTCA cell proliferation assay and the average cell index is shown for 72 h. Each data point is represented by mean ± SD (n =3).